Rigel Pharmaceuticals Stock Shows Every Sign Of Being Modestly Undervalued

Disclaimers: GuruFocus.com is not operated by a broker, a seller, or a registered investment decision adviser. Underneath no situation does any information posted on GuruFocus.com represent a recommendation to buy or offer a stability. The facts on this site, and in its linked newsletters, is not intended to be, nor does it represent, expenditure information or recommendations. The gurus could acquire and offer securities prior to and after any distinct posting and report and facts herein is revealed, with regard to the securities mentioned in any post and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or 3rd party for any damages of any variety arising out of the use of any articles or other content published or accessible on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, which includes, without limitation, any expense losses, missing profits, dropped prospect, exclusive, incidental, indirect, consequential or punitive damages. Previous efficiency is a lousy indicator of long run functionality. The information on this web-site, and in its relevant newsletters, is not intended to be, nor does it represent, investment decision advice or tips. The details on this site is in no way confirmed for completeness, precision or in any other way. The gurus mentioned in this web-site are not affiliated with GuruFocus.com, LLC.
Inventory prices delivered by InterActive Information. Basic enterprise information supplied by Morningstar, current day-to-day.

Next Post

Apr 19, 2021 - Zynga Inc (ZNGA) CFO James Gerard Griffin Sold $557,952 of Shares

CFO of Zynga Inc (30-12 months Financial, Insider Trades) James Gerard Griffin (insider trades) marketed 52,637 shares of ZNGA on 04/19/2021 at an normal price of $10.6 a share. The complete sale was $557,952. Zynga Inc is engaged in establishing, marketing, and working social video games. Its online games involve […]